SLC18A1 Antikörper (Middle Region)
Kurzübersicht für SLC18A1 Antikörper (Middle Region) (ABIN927535)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Kreuzreaktivität
- Maus, Ratte (Rattus)
-
Aufreinigung
- Purified
-
Immunogen
- SLC18 A1 antibody was raised in rabbit using the middle region of SLC18 1 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
SLC18A1 Blocking Peptide, (ABIN936277), is also available for use as a blocking control in assays to test for specificity of this SLC18A1 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- SLC18A1 (Solute Carrier Family 18 (Vesicular Monoamine Transporter), Member 1 (SLC18A1))
-
Andere Bezeichnung
- SLC18A1
-
Hintergrund
- The vesicular monoamine transporter acts to accumulate cytosolic monoamines into vesicles, using the proton gradient maintained across the vesicular membrane. Its proper function is essential to the correct activity of the monoaminergic systems that have been implicated in several human neuropsychiatric disorders. The transporter is a site of action of important drugs, including reserpine and tetrabenazine. Synonyms: Polyclonal SLC18A1 antibody, Anti-SLC18A1 antibody, solute carrier family 18, vesicular monoamine, member 1 antibody, CGAT antibody, VAT1 antibody, VMAT1 antibody.
Target
-